Life Insurance Search

A group of UK scientists has been awarded £2.8 million to work on a drug that could ease the suffering of hundreds of thousands of heart disease patients who cannot take beta-blockers.

Some 2.6 million people in the UK suffer from heart disease and most have their symptoms managed by beta-blocker drugs which stop adrenaline from forcing the heart to work too hard, Science Daily reports.

However, beta-blockers make the symptoms of respiratory conditions like asthma worse.

Now researchers at the University of Nottingham will use money from the Wellcome Trust to work on producing a beta-blocker that treats heart problems without exacerbating respiratory problems.

Ted Bianco from the Wellcome Trust said: "We know that beta-blockers save lives in patients with heart disease, so making them safe for those unlucky enough to have a respiratory disorder as well is a clinical imperative."

People who are concerned how their family would manage to pay the mortgage should the worst happen may want to consider taking out a life insurance policy such as decreasing term life insurance.